InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
5.78
+0.10 (1.76%)
At close: Aug 28, 2026, 4:00 PM EDT
5.86
+0.08 (1.38%)
After-hours: Aug 28, 2026, 5:49 PM EDT
Company Description
InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally.
The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector.
The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
InterCure Ltd.
| Country | Israel |
| Founded | 1994 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 285 |
| CEO | Alexander Rabinovich |
Contact Details
Address: 85 Medinat ha-Yehudim Street Herzliya, 4676670 Israel | |
| Phone | 972 7 746 05012 |
| Website | intercure.co |
Stock Details
| Ticker Symbol | INCR |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | ILS |
| IPO Price | $0.00 |
| CIK Code | 1857030 |
| CUSIP Number | M549GJ111 |
| ISIN Number | IL0011063760 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Alexander Rabinovich | Chief Executive Officer and Chairman |
| Amos Cohen | Chief Financial Officer |
| Einat Zehavi | Vice President of Sales |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 27, 2026 | 6-K/A | Filing |
| Aug 26, 2026 | 6-K | Report of foreign issuer |
| Aug 24, 2026 | 6-K | Report of foreign issuer |
| Aug 19, 2026 | D | Notice of Exempt Offering of Securities |
| Aug 11, 2026 | 6-K | Report of foreign issuer |
| Aug 4, 2026 | 6-K | Report of foreign issuer |
| Jul 27, 2026 | 6-K/A | Filing |
| Jul 22, 2026 | 6-K | Report of foreign issuer |
| Jun 22, 2026 | 6-K | Report of foreign issuer |
| Jun 15, 2026 | 6-K | Report of foreign issuer |